Management of Spontaneous Abortion Among Commercially Insured Individuals in the United States After
JAMA 10.1001/jama.2026.6344May 18, 2026 at 11:00 AM EDT
Was the decision associated with changes in the clinical management of spontaneous abortion in states with trigger abortion bans?In this cross-sectional study of 123 598 commercially insured individuals with spontaneous abortion, trigger bans were associated with a 2.8 percentage point increase in expectant management and a 2.2 percentage point decrease in medication management. Among individuals receiving medication, trigger ban states had a 13.8 percentage point increase in misoprostol-only regimens relative to the evidence-based mifepristone plus misoprostol combination.State-level abortion bans were associated with shifts in spontaneous abortion management away from evidence-based care, with implications for the hundreds of thousands of individuals experiencing miscarriage annually in affected states.
Link to the article in your story
We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)
Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Need more information? Contact us.